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How is success achieved by individuals
innovating for patient safety and quality in
the NHS?
Laura Sheard1*, Cath Jackson2 and Rebecca Lawton1,3
Abstract
Background: Innovation in healthcare is said to be notoriously difficult to achieve and sustain yet simultaneously
the health service is under intense pressure to innovate given the ever increasing demands placed upon it. Whilst
many studies have looked at diffusion of innovation from an organisational perspective, few have sought to
understand how individuals working in healthcare innovate successfully. We took a positive deviance approach to
understand how innovations are achieved by individuals working in the NHS.
Method: We conducted in depth interviews in 2015 with 15 individuals who had received a national award for being
a successful UK innovator in healthcare. We invited only those people who were currently (or had recently) worked in
the NHS and whose innovation focused on improving patient safety or quality. Thematic analysis was used.
Findings: Four themes emerged from the data: personal determination, the ability to broker relationships and make
connections, the ways in which innovators were able to navigate organisational culture to their advantage and their
ability to use evidence to influence others. Determination, focus and persistence were important personal
characteristics of innovators as were skills in being able to challenge the status quo. Innovators were able to connect
sometimes disparate teams and people, being the broker between them in negotiating collaborative working. The
culture of the organisation these participants resided in was important with some being able to use this (and the
current patient safety agenda) to their advantage. Gathering robust data to demonstrate their innovation had a
positive impact and was seen as essential to its progression.
Conclusions: This paper reveals a number of factors which are important to the success of innovators in healthcare.
We have uncovered that innovators have particular personal traits which encourage a propensity towards change and
action. Yet, for fruitful innovation to take place, it is important for relational networks and organisational culture to be
receptive to change.
Keywords: Innovation, Positive deviance, Qualitative research, Patient safety, Healthcare organisations
Background
Healthcare innovation has been defined as “a novel set of
behaviours, routines and ways of working that are directed
at improving healthcare outcomes, administrative effi-
ciency, cost effectiveness or users’ experience and that are
implemented by planned and co-ordinated actions” [1].
The healthcare sector in the United Kingdom is under
continual pressure to innovate given the ever increasing
efficiency demands placed upon it [2]. Yet, the challenges
of implementation and diffusion mean that achieving sus-
tained innovation in healthcare is notoriously difficult [3].
A number of interacting factors have been identified to
underpin the speed of implementation and diffusion as
well as its sustainability [4]. These relate to the innovation
itself, the intended adopters, communication and influ-
ence, both the inner and outer organisational/system con-
text and the process of implementation [1].
Ever since Roger’s seminal work on diffusion of innova-
tions theory [4], a body of literature has emerged concern-
ing how innovations are spread, diffused or implemented
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in many sectors including healthcare. Several recent pa-
pers have examined healthcare innovation in different
ways. McMullen et al. (2015) used the diffusions of inno-
vations model to understand the results of a trial which
tested a novel rapid HIV test in UK primary care [5]. Illott
et al. (2012) assessed the implementation of healthcare in-
novations arising from a region in the North of England
[2]. Barnett et al. (2011) were interested in factors which
obstructed or facilitated the implementation and diffusion
of innovation in healthcare organisations [6]. Other re-
search teams have looked at innovations in relation to a
precise clinical area e.g. why transcatheter aortic valve im-
plantation showed rapid diffusion in Germany but not
elsewhere [7]. These studies have addressed the issue of dif-
fusion and spread, but significantly less work has empha-
sised how innovation is developed and achieved or the role
of individuals in producing healthcare innovations. Due to
the paucity of knowledge in this area, our research team
became increasingly interested in understanding how
innovation is achieved by individuals in the NHS with
regards to patient safety and quality.
Patient safety is a key government and NHS concern
[8] but little is known about how individuals working
within healthcare organisations are able to achieve inno-
vations specific to patient safety and quality. Attempts to
improve patient safety within healthcare organisations
often rely on identifying when patient safety is compro-
mised via methods such as mortality reviews, audits and
incident reporting. The emphasis on ‘find and fix’ or
“what goes wrong and how often, why errors occur, and
who or what is at the root of the problem… tell us little
about the presence of patient safety, alerting us instead
to its absence” [9]. Despite this negativity, the majority
of care that is delivered is of a high quality and safe [10].
Approaches which focus on strengths and resources -
looking at why things go right in order to learn from
success – are beginning to gain credence [9]. One such
approach is that of ‘positive deviance’ [11]. Positive devi-
ance has its roots in international public health research
[12] but has recently begun to be applied to western
healthcare settings to address patient safety topics such
as reducing surgical site infections [13], and the promo-
tion of hand hygiene [14]. A central tenent of the posi-
tive deviance approach is that solutions to problems
facing a given community usually exist amongst certain
members of that community, which can then be taken
and spread to other members [12]. Despite facing similar
constraints as others, ‘positive deviants’ are able to suc-
ceed by demonstrating different or uncommon behav-
iours [15]. Most studies which have identified and
conducted work with positive deviants have been fo-
cused at the level of the organisation rather than the in-
dividual [15]. Of those studies which have focused on
individual positive deviants in healthcare, most use
quantitative methods [14, 16]. One exception is Kim
et al. (2008) who identified the strategies used by posi-
tively deviant nurses (and patients) when focusing on
communication about family planning programmes in
Indonesia [17]. There is little other literature of a suffi-
cient methodological quality regarding individual posi-
tive deviants. In this study, our aim is to understand
how individuals working within the NHS manage to im-
plement innovations which benefit patient safety. This is
one of the first studies to use the positive deviance ap-
proach to examine how innovators for quality and safety
in the NHS achieve success.
Our original research questions were:
-What do successful individuals believe helped them to
achieve their innovation?
-What do innovators believe they do differently to
others with a similar role and status?
-Do the innovators see themselves as unusual? How
and in what ways?
-What approach to leadership do the innovators take?
Methods
Study design
A qualitative research design was employed, undertaking
semi-structured in depth interviews with innovators in pa-
tient safety and quality. In depth interviews were selected
because they often lead to rich narratives, which permit
the researcher to analyse how the participants make sense
of the topic under investigation [18]. As this study was ex-
ploratory in nature, we did not begin with an a priori hy-
pothesis. We took a positive deviance approach whilst
grounding ourselves in an applied health services research
paradigm. Ethical approval for the study was granted by
the University of Leeds in March 2015.
Participants and recruitment
We set out to interview around 15 innovators working
in the area of patient safety and quality, within the NHS.
Potential participants were identified from the Health
Services Journal (HSJ) supplement ‘Top 50 innovators in
Healthcare’ in 2014 [19] and 2013 [20]. HSJ is a weekly
journal read by healthcare staff and NHS managers. Po-
tential participants were people who had won a national
award for their work in innovation in healthcare. We se-
lected participants to approach from the HSJ Innovators
awards list whose innovation had made a substantial
contribution to patient safety or quality (or had the po-
tential to do so), as judged by all three authors. They
also had to be a healthcare professional currently or re-
cently working for the NHS. We excluded innovators if:
their area was not patient safety or quality, their work
had no direct impact on patients, their work related only
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to a technical invention, high level infomatics or cost ef-
fectiveness/cost reduction.
Twenty two potential participants were emailed by LS
and invited to take part in an interview and 15 agreed to
take part (68% response rate). For those individuals who
responded, a participant information sheet and consent
form were then e-mailed to them. An interview date
was subsequently arranged. Participants completed and
returned a consent form prior to the interview. As this
study was with ‘elite’ participants, a small sample size is
more appropriate than for a qualitative study under-
taken with patients or the public [21]. We anticipated a
priori that around 12–15 participants would be needed to
draw general conclusions about innovators in safety and
quality in healthcare [21]. Table 1 provides a short de-
scription of each participant’s innovation. The innovations
described were varied. Although they all concentrated on
patient safety and quality, some related to developing new
processes or different ways of working whilst others
sought to spread or scale up already existing ideas.
Data collection
Fifteen interviews were conducted by LS and CJ between
June and September 2015. LS is a medical sociologist
and CJ is a health psychologist. Both have worked in
health services research for almost fifteen years each and
have significant qualitative expertise. Both are educated
to doctorate level in their respective fields. Of the fifteen
interviews, five interviews were conducted face-to-face
in the offices of participants and ten were conducted
over the telephone. The approach was dependent on the
location and/or preferences of the participant.
All interviews were conducted using a topic guide to
ensure consistency across participants; however, the for-
mat was flexible in order to allow participants to voice
what they considered important. Interviews began with a
discussion of the innovation which led to their HSJ
award, then progressed to examining the levers around
successful innovation, paying particular attention to the
individual circumstances of the participant and their role
(including leadership) in the NHS organisation where
they worked. The behaviour change wheel [22] informed
the interview questions. This considers capability, motiv-
ation and opportunity for behaviour (in this case,
innovation). Using a positive deviance approach as outlined
previously, we explored whether these innovators were
doing anything differently to other clinicians, and if so, how
they managed to become a positive deviant in terms of
innovation. Interviews lasted between 20 and 50 min and
were all digitally audio-recorded. The voice files were tran-
scribed verbatim by a professional transcriber.
Analysis
We employed thematic analysis [23]. This approach is
both inductive (themes emerge from the data and are
not imposed upon it by the researchers) and iterative
(data collection and analysis occur simultaneously). The
iterative nature of the analysis meant that preliminary in-
sights gathered during fieldwork then assisted in partially
shaping the resultant coding framework. Comparative
analysis was also carried out; this method allows data from
different participants to be compared and contrasted. Dis-
cordant cases were actively sought throughout the analysis
and emerging ideas and themes were modified in re-
sponse. Data analysis involved a process of organising the
Table 1 The main innovation of participants
P1 Led the implementation and adoption of an organisational development approach within a NHS Hospital Trust, working with teams in
difficulty.
P2 Took the concept of enhanced recovery in surgical patients and introduced it for medical patients.
P3 Improved the use of health informatics in the NHS, setting up systems to collect and review real-time performance data.
P4 Introduced the use of PROMs with patients undergoing orthopaedic surgery to improve the efficiency of follow-up clinics.
P5 Designed a new, safer technique for glaucoma surgery including anti-scarring treatment.
P6 Developed a rehabilitation pathway using digital media to engage patients more in the process.
P7 Redesigned patient pathways to improve outcomes for dialysis patients as well as deliver efficient and more sustainable dialysis services.
P8 Led the implementation and adoption of an organisation-wide intervention to improve patient safety in an NHS hospital trust.
P9 Scaled up and rolled out a tele-health initiative across a region of England
P10 Lead the implementation of specialist geriatric-led service for older elective surgical patients
P11 Developed a patient experience campaign focusing on improving communication between staff and patients
P12 Implemented and scaled up a novel method for stimulating successful communication in healthcare teams in order to improve patient safety
outcomes
P13 Led a large scale reconfiguration of the centralisation of stroke services in a major city in the UK
P14 Developed an approach to improve the process of ward rounds in order to reduce errors relating to patient safety
P15 Led the transformation of primary care services in a major city in the UK
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data, descriptive coding, interpretive coding, writing and
theorising. Data were managed using a qualitative com-
puter software package (NVivo) to aid sorting and cat-
egorisation of the data analysis process. LS and CJ
developed the coding framework collaboratively after in
depth readings of four transcripts considered typical of
the dataset. CJ then coded all the transcripts and LS con-
ducted the next level of analysis and writing. Agreement
regarding interpretation was reached through consensus
discussion.
Findings
Four themes were identified from the analysis: a) personal
determination b) brokering relationships and making con-
nections c) navigating organisational culture d) using evi-
dence to influence others. Below, we outline broad factors
across the themes which allow for an exploration of what
helped these participants achieve their innovations and
potential ways in which they were deviating from the
norm. The themes arose inductively from the interviews
conducted with the 15 participants and each has been as-
cribed a number to protect their identity.
Personal determination
In seeking to discover what allows for some individuals
working clinically within the NHS to develop innova-
tions on a national level, it can be said that these people
are driven to an exceptional level to provide better care
for their patients. They were persistent, energetic, deter-
mined and compelled to be a clinician that went consist-
ently above and beyond their normal ‘day job’ in order
to make real change within the health service. Most of
the participants described their innovation as happening
outside of their normal working hours and indeed some
vocalised that it was largely impossible to innovate
within the time constraints of an average clinical work-
load. Being single minded and focussed on what they
wanted to achieve was a strategy described by many of
the innovators. Taking on the role of an innovator was
said to be hard and something that could easily be given
up if the inner determination to succeed and persever-
ance was not fully present, with two participants
remarking “you need grit to make change” (P15) and:
It’s about believing in what you do and someone
saying ‘you’re the guy with the bee in your bonnet’
(P4).
Divergence existed in the sample as to whether these
were a group of people who were constantly innovating
(“serial innovators”) or whether they had one main idea
which they sought to propel forward and spread. A few
participants did not feel comfortable being referred to as
innovators and somewhat rejected the label.
Three participants spontaneously described them-
selves as “mavericks”. Over half the sample talked
about how they felt it was necessary to challenge the
status quo during the course of developing or imple-
menting their innovation – either directly or as a re-
sult of their innovation being unduly stymied by
various factors. Challenging the status quo in order to
bring about innovation was said to be difficult and had
led to resistance from others. One participant
remarked: “people don’t want the innovation, they
want the status quo” (P1) whilst another said “people
always think something new is wrong” (P5). Choosing
to be known as an innovator was said to be hard and
sometimes unwelcoming:
I ended up being seen as a radical and a troublemaker
rather than somebody who’s fighting every day to try
and make it a little bit better for the patients and for
the staff I work with (P14)
It was felt that clinicians needed to be at a certain
point of seniority in their career where “rocking the
boat” (P3) or “going against the trend” (P7) was not per-
ceived as too detrimental to their status amongst their
colleagues and within their organisation. Overall, we ob-
served distinct personal traits related to determination,
focus, persistence and being able to challenge the status
quo were essential to ensure innovation happened.
Brokering relationships and making connections
Innovators often felt that a critical part of their role was
as a broker in bringing teams together and, in a lot of
cases, encouraging people in divergent specialties to talk
to each other and work together. This was a critical part
of the journey of how their innovation was achieved and
this ‘broker’ role sometimes differentiated them from
other clinical peers. The ability to connect different
people and connect different ideas together was import-
ant. Part of this role was described by some as about be-
ing able to convincingly market their ideas to others
with P3 stating “you have to be a politician and a sales-
man”. Sometimes this role was difficult if participants
did not already have established networks and were hav-
ing to track down the appropriate people to assist them.
Several participants remarked that they had to step out-
side of their own clinical area in order to deliberately
build up relationships with other specialities to move
their innovation forward:
[We’re] trying to show people how they can be
innovative around services and how you can get
collaboration going between specialities that haven’t
traditionally collaborated, like [innovator’s team],
anaesthetists and surgeons (P10).
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Innovations which required cross working from diverse
sections of the health system were said to be difficult to
implement or set up but fundamentally necessary.
Of importance to the spread of some innovations were
the fostering of collaborations or relationships between
different directorates or wards of the same hospital who
may not usually work together. In some cases, this was
through local clinical networks (both formal and infor-
mal) or by clinical peers informally attesting to the value
of the innovation with each other. P12 described making
her innovation as easy as possible for people to test on
their ward in order to foster uptake. Many innovators
spoke about social media and in particular the import-
ance of Twitter in order to disseminate ideas around
innovation. Some participants were already opinion
leaders on Twitter and used this platform to engage
others in their innovation idea whilst others took to
Twitter and became recognised as a result of public at-
tention garnered from their innovation. In the case of a
few participants, Twitter activity propelled debate about
their innovation onto a global platform.
Most participants discussed the wider team they re-
sided in and how these people and their skills were inte-
gral to the success of the innovation. Comment such as
“it could not have happened” without the wider team
were prevalent throughout the sample. Many innovators
directed praise and attention for the achievement of the
innovation to the wider team in which they sat. For
some, this involved feeling uncomfortable about being
singled out to receive the innovation award as an indi-
vidual when they felt that several others had contributed
just as equally:
I don’t like the attention that comes with it because I’d
rather the attention be on the team and the data, like
the fact that the team’s made a difference and the data
is amazing, like in terms of the improvement. So I just
feel uncomfortable with like individuals taking recognition
for something that isn’t really about individuals (P12)
Navigating organisational culture
The setting and context in which participants worked
was contentious in relation to whether they believed it
had allowed them to succeed (or not) with regards to
their innovation. In exploring this theme, it cannot be
determined whether the ability to navigate organisational
culture and use it to their advantage is part of how this
group of participants deviate from the norm. Partici-
pants variously outlined how organisational politics (on
a micro, meso and macro level) had impacted their at-
tempts at innovation. Whilst the majority of the sample
discussed this aspect of innovation, it was interesting to
see that there was an equal split between whether partic-
ipants believed the culture of the organisation had either
facilitated or blocked their attempts to innovate. A mi-
nority of innovators discussed influential chief execu-
tives, medical directors or managers who had buoyed
their ability to innovate. In a few of these cases, these
participants were encouraged by superiors in order to
intentionally provide provocation or disrupt normal pro-
ceedings. P2 gave the example of being selected for cer-
tain hospital committees in order:
To challenge, hopefully not in an unpleasant way, but
to raise the questions and bring ideas from elsewhere
(P2).
The context and circumstances in which innovators
were navigating (or trying to navigate) organisational
culture often played a large part in seeing their
innovation to fruition. The safety and quality agenda was
said to have come to the fore in the UK over the past
ten years and five participants discussed how they felt
this had facilitated their innovation. Some participants
talked about the organisation in which they worked be-
ing culturally ready for change and the innovation taking
hold because it was introduced “in the right place at the
right time” (P13). This was particularly the case for in-
novations which involved large scale system change,
which were sensitive to national policy or a change in
governmental direction. It is interesting here to contrast
the experiences of two participants - P13 and P14. P13
presided over a £20m radical structural reconfiguration
of acute care which encountered comparatively little re-
sistance despite anticipating the opposite. This contrasts
with P14 who described feeling frustrated that his rela-
tively small scale innovations were not taken on board
by management within the organisation where he
worked. This was despite some of these innovations –
mostly relating to improving processes on hospital wards
– achieving international attention and being imple-
mented at hospitals in several other countries.
Related to P14’s experience, several participants iter-
ated how hierarchy and bureaucracy in the NHS has im-
peded their innovative spirit and, in a few cases, their
ability to spread the innovation they had created.
Amongst this group of six participants, there was a sense
of frustration about how, at times, it seemed exception-
ally difficult to be able to embed or spread new ideas or
practices. This was sometimes related to the nature of
the innovation itself if it sought to change culture within
healthcare. Responsiveness to innovation within the
NHS was said to be slow and clunky, with many regula-
tory hurdles to overcome, as P15 describes:
The difficult thing is the timescale that the
bureaucracy works at is about a thousandth of the
time that I work at. So it’s very frustrating to know
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what needs to be done and to have to wait a year
whilst all the dots are dotted and the crosses are
crossed. I think this is the story of the NHS really…I
think innovation now, the system is such a mess, it’s so
muddled and sticky (P15)
Coupled with the above was the issue of stability and
sustainability within innovative spaces. There was said to
be a lack of a culture to nurture wider sustainability for
innovation. Sometimes the emphasis was put on the in-
dividual who had made the innovation to sustain it long
term which was seen as unfeasible by innovators them-
selves, as P7 remarks:
Just because I can put in a lot of extra time cos I
believe in it, that can’t be the model of sustainability.
Somebody has to take it off you and create
sustainability around it; in the NHS nobody does that.
So when you’ve done something and it seemed to have
worked, they’ll expect you to carry the can (P7)
A few participants remarked that it was dangerous for
just one person or a small group of people to be pushing
an innovation forward as the sustainability of the
innovation was liable to collapse if it was not embedded
more widely. Finances were often integral to the above
issue and a couple of participants remarked how there
was a lack of willingness to take innovation forward by
the organisation if little or no money was attached to it.
Conversely, one participant had achieved re-design of a
hospital service by using small pots of money and build-
ing up incrementally in order to show that the new
model worked before applying for large scale funding.
An additional factor which stymied innovation was re-
sistance from clinical peers who did not see the benefit,
think it would make any difference or that it would be
possible to introduce. This approach had frustrated
some participants when the ultimate benefit of testing
out the innovation was to improve patient safety or care.
Some peers were said to not be willing to step outside
their comfort zones in order to try new ways or pro-
cesses of working. Particular reticence was said to be en-
countered when innovations sought to change clinicians’
ways of thinking. P10 outlines the resistance she experi-
enced at first:
When we first started there was a lot of resistance; I
don’t think, you know, people really understood why or
how [team] could add value to something as high tech
as surgery and anaesthesia…would we be taking a
lead where we shouldn’t be taking a lead? How that
was going to infringe on their own clinical areas…
Some of the consultants initially said that they didn’t
want us seeing their patients (P10)
Notable exceptions existed to the above with P12 being
surprised at the ease with which her innovation was
adopted by clinical peers throughout the hospital and then
the wider region. P11 seemed amazed at the speed and
coverage her innovation took hold in the public con-
sciousness and throughout healthcare nationally and inter-
nationally. It is important to note that few participants
spoke about how their innovation had been completely
curtailed by bureaucracy or a lack of sustainability, al-
though there was a sense that some innovations pro-
gressed slower than would have been desired.
Using evidence to influence others
Half the sample discussed the role of data (usually statis-
tical or quantitative) to support the robustness of their
innovation. The predominant use of data was often cited
as “evidence” to demonstrate to peers and others that
the innovation had a positive impact on patient safety or
quality and therefore should be taken forward by others.
Five participants attested to increasing attention being
given to their innovation when peers saw the difference
it was making to clinical care or processes via the pres-
entation or publication of hard data. This was often seen
as incremental attention over time as data started to
show that the innovation was successful. P12 demon-
strates several of the above points:
Quite quickly we started to see results, improvement in
reducing falls, and that gave a massive sort of
momentum and belief that it makes a difference. And
then basically we then got lots of natural spread,
probably six months later...I was confident we’d got
data to say to my colleagues, can you do it seven days
a week, you know, five days a week we’ve achieved this,
imagine what we could do if we did seven days a
week?... Normally you send an email asking people to
do something, and you’ll get like a flurry of resistance.
But there was no resistance and a few people said, you
know “Great data, of course I’ll do that.” (P12)
Some participants were able to demonstrate statisti-
cally significant statistics such as reductions in mortality,
reduced hospital admissions, shortened lengths of stay
and significant improvement in falls data. These results
had been persuasive in the spread of the innovation re-
gionally and nationally. Getting quick, robust data which
demonstrated the innovation worked was influential to
some participants whereas others worked for several
years to build up a robust dataset before they could
show the innovation had positive impact. Several partici-
pants mentioned the importance of ensuring that data
collection processes were built into the testing or roll
out of the innovation.
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Discussion
In this study, we used the positive deviance approach to
learn from individuals who are high profile innovators
within the NHS in order to explore their perceptions of
how they achieved their innovation. When investigating
‘what works’ at the level of individual, we found that the
main factors were around: personal determination, the
ability to connect people and teams, the ways in which
innovators were able to use organisational culture to
their advantage and their ability to use evidence to influ-
ence others. It is important to acknowledge that deter-
mination, focus, persistence were important personal
characteristics as were skills in challenging the status
quo. Innovators were able to connect sometimes dispar-
ate teams and people, being the broker between them in
negotiating collaborative working. Some participants
were able to use the culture of their organisation and
the current patient safety agenda to their advantage
(others found organisational culture stifling and this is
discussed further below). Gathering robust data to dem-
onstrate that their innovation had a positive impact was
seen as essential to its progression.
The majority of these themes are reflected in the
broader literature on how change takes place in organi-
sations. For example, the Consolidated Framework for
Implementation Research [24], − which is a meta-
theoretical conceptual framework that synthesizes con-
structs from theories about innovation, organisational
change and knowledge translation, amongst others - is
particularly relevant. Two of its five core constructs
are pertinent: inner setting and characteristics of indi-
viduals. The inner setting construct outlines how im-
portant the quality of social networks and informal
communication are within an organisation. Relation-
ships between individuals and a sense of ‘community’
are said to sometimes be more important than indi-
vidual attributes. This relates heavily to our finding
that the ability of our participants to connect people
and teams was often intrinsic to the success of their
innovation. However, the authors of the framework
[24] state that personal attributes such as motivation,
values, capacity and intellectual ability have received
inadequate attention by those interested in how
change is implemented. A major theme arising from
this study was about the personal attributes and, es-
sentially, the personal determination which this group
of participants had to push forward their innovation.
The fact that these intrinsic traits have been little
studied in relation to organisational change is perhaps
not surprising given that it may seem ‘common sense’
that what allows individuals to achieve innovation is
their inherent sense of self. However, this study has
shown which personal traits the participants identified
themselves as being important for innovative practice.
It is interesting to see that although our explicit focus
was on the positive, many of the participants spontan-
eously discussed what had hindered their particular
innovation or, more generally, their innovative creativity
or practice. This negative element of the findings can be
derived across the main themes although mainly relates
to that of ‘organisational culture’ particularly issues of
bureaucracy, sustainability and resistance from peers.
We felt it was important for the content of the themes
to arise inductively from the dataset and so we have paid
attention to describing the holistic account of what par-
ticipants felt was important to them when asked to talk
about how they achieved their innovation. But in doing
so we have unveiled elements of ‘the way things are
done’ in the NHS which frustrated – and sometimes
hindered – a number of our participants. Of interest is
the fact that these participants were working at a high
level and usually mostly in influential positions. There-
fore, the implications for how innovations take hold and
spread within the health service needs thought and at-
tention paid to it if those at the top of the structure have
difficulty. This ties into the wider literature about the in-
ability of shop floor NHS staff to make improvements to
services [25]. Sometimes, it not enough for a clinician to
simply have a great idea and the determination to suc-
ceed. Success is often related to the complex interplay of
services from different disciplines working together and
a culture of ‘organisational readiness’ to change [26].
Our overt focus was on innovators who were working
in the patient safety and quality field. It is therefore in-
teresting that despite being encouraged to talk during
the in depth interviews about the specifics of their
innovation, many of the main messages arising from the
findings section are general in nature and could apply to
innovation in disparate fields. Two of the themes are of
particular interest here – brokering relationship and
making connections; navigating organisational culture.
For instance, innovators were often trying to influence
groups of wider colleagues with whom they may not or-
dinarily interact to address specific clinical issues. There-
fore, the importance of relational aspects of the
innovation was voiced as integral to its perceived success
by our group of participants. That the findings are gen-
eral rather than specific is useful as this may allow for
these insights to be applicable to those working in
healthcare areas other than patient safety and quality.
The concept of leadership was part of our original
focus and one of the a priori research questions. The
topic guide contained several questions about leadership
and participants answered these questions to varying de-
grees. However, when analysing the dataset we did not
get the impression that leadership per se was a point of
interest to these participants. In fact, leadership was
rarely spontaneously mentioned and answers to the
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topic guide questions about leadership were sometimes
perfunctory. Therefore, we did not include leadership as
a theme within our write up. Contemporary literature
on leadership within the NHS highlights a discursive
move from previous forms of traditional hierarchical
leadership to new forms of distributed leadership where
people have the skills and relationships to work across
multiple levels and with a variety of stakeholders [27].
Martin & Learmonth (2012) [28] note that leadership is
said to be no longer exercised by just those in formal po-
sitions of authority but “something to be brought out
across and beyond the health service”. For major change
to be embedded in a healthcare system, it has been
shown that elements of both hierarchical and distributed
leadership are necessary [29]. It is interesting that none
of our participants explicitly spoke about distributed
leadership as an approach they take. Yet, in describing
how they approached the task of delivering the
innovation, this is the style of leadership most par-
ticipants implicitly adopted in order to connect people
and teams, sometimes in challenging situations or
environments.
The findings of this paper suggest that innovations are
not easy to achieve in the current NHS and that
innovation is certainly not conceived as part of the ‘day
job’ of clinicians. When seeking those people for roles
that require innovation, recruiters may benefit from pay-
ing particular attention to the ability of applicants to
connect people and to challenge the status quo. Deter-
mination and a sense of moral responsibility to improve
patient care may also be traits worth examining. Lessons
for NHS organisations also emerge from these data. At a
senior level, recognition of and support for innovators to
bring different people together to address a problem
may be key, particularly where this can bypass bureau-
cracy that might otherwise stymie progress. Indeed this
is one of seven recommendations for diffusing innova-
tions outlined by Berwick (2003) [30]. The problem re-
mains, however, how can those working in healthcare be
supported to become innovators? One approach is to
provide an opportunity for aspiring innovators to be em-
bedded within a community of similarly minded peers at
a local and national level. This approach is reflected in
the Q community [31] established by NHS England and
the Health Foundation to improve the quality of health
and care services. The ability to call on similar others for
advice and the opportunities for learning together that
such a community might provide could help future in-
novators to overcome the challenges they so often face.
This study has important implications, recognising, as it
does, the importance of relationships across the health-
care setting for making change happen. As well as sup-
porting innovators, leaders in healthcare organisations
could engage in strategies to encourage a culture of
innovation. These might include opportunities for multi-
disciplinary training and projects and engaging frontline
staff in improvement projects. Other initiatives such as
shadowing across staff groups, improvement training
and mentoring that encourage a better understanding of
the health system as a whole, may well serve to help in-
novations develop and flourish.
Strengths and limitations
To our knowledge, this is the first study to take a posi-
tive deviance approach to understand how innovations
which benefit patient safety are achieved within the
NHS. We interviewed a sample of exceptional innova-
tors who were able to provide insight at the highest level
of innovation in patient safety – across a range of types
of innovations in different clinical areas. One limitation
of our study could be the small sample size although, as
previously described, interviewing ‘elite’ participants al-
lows for this. In taking a positive deviance approach, we
were explicitly looking for the factors which allow inno-
vations to succeed in the NHS. It could be that had we
conducted a more traditional ‘barriers and levers’ style
study (such as Barnett et al. [6]) which paid equal atten-
tion to what discourages or prevents innovation then we
would have gained a more rounded view of patient safety
and quality innovation. However, whilst describing the
process of innovating, participants did articulate the hur-
dles they had to overcome. Perhaps by describing how
they achieved this we learn more about what is required
by innovators, their colleagues and managers to deliver
improvements to quality and safety. Finally, our sample
of participants were those drawn from a national award
list of NHS innovators, representing highly successful
and – for the most part – influential people. We may
have garnered different answers to our research ques-
tions if we had interviewed participants who were per-
haps not known on a national level and were delivering
innovations with a smaller impact or reach.
Conclusion
We interviewed patient safety and quality innovators
using a positive deviance approach to understand how
they achieve success. The main factors identified were: i)
personal determination of the individuals including their
ability to challenge the status quo, ii) their capacity to con-
nect people and teams, and encourage collaborative work-
ing, iii) the ways in some which innovators were able to
use organisational culture to their advantage and iv) using
evidence to influence others. Whilst innovation in health-
care is said to be difficult to achieve, we have uncovered a
number of the key aspects which we believe may lead to
successful innovation by individuals working in the NHS.
These findings can be used by those who recruit, train
and support potential innovators in the NHS and those
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who are responsible for setting the policy agenda. For suc-
cessful innovation to occur, both the relational and struc-
tural position of the innovator are critical.
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